Adjuvant Properties of Aluminum and Calcium Compounds
- 1 January 1995
- book chapter
- Published by Springer Nature
- Vol. 6, 229-248
- https://doi.org/10.1007/978-1-4615-1823-5_8
Abstract
Aluminum compounds, including aluminum phosphate (AIPO4), aluminum hydroxide [Al(OH)3], and alum-precipitated vaccines (historically referred to as protein aluminate), are currently widely used with human vaccines. These adjuvants have often been referred to as “alum” in the literature. Alum, which chemically is potassium aluminum sulfate [KA1(SO4)2.12H2O], has not been used as an adjuvant as such. Rather, it was used to partially purify protein antigens, mainly tetanus toxoid (TT) and diphtheria toxoid (DT) by precipitating them in the presence of anions including phosphate and bicarbonate ions resulting in a mixture of compounds, mainly aluminum phosphate and aluminum hydroxide (Holt, 1950; Aprile and Wardlaw, 1966). The amounts of aluminum phosphate and aluminum hydroxide in the mixture depended on the amount and nature of anions present in the reaction mixture and adjustment of pH of the final product with sodium hydroxide (Relyveld, 1986; Nicklas, 1992). Although alum-precipitated TT and DT had been used for human immunization for many years, their use has declined considerably because of variations in production of alum-precipitated toxoids (van Ramshorst, 1949; Holt, 1950; Aprile and Wardlaw, 1966; Gupta et al., 1993). Referring to all aluminum adjuvants as “alum” is misleading because aluminum hydroxide and aluminum phosphate have different physical characteristics (see Chapter 9) and differ in their adjuvant properties.Keywords
This publication has 80 references indexed in Scilit:
- Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvantsVaccine, 1994
- Comparison of Adjuvant Activities of Aluminium Phosphate, Calcium Phosphate and Stearyl Tyrosine for Tetanus ToxoidBiologicals, 1994
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Aluminum saltsResearch in Immunology, 1992
- The adjuvanticity of Algammulin, a new vaccine adjuvantVaccine, 1991
- Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old childrenThe Journal of Pediatrics, 1990
- Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenThe Journal of Pediatrics, 1988
- Elevation of Levels of IgE Antibody to Tetanus Toxin in Individuals Vaccinated with Diphtheria-Pertussis-Tetanus VaccineThe Journal of Infectious Diseases, 1982
- The Influence of Various Adjuvants on the Metabolism of Phospholipids in MacrophagesInternational Archives of Allergy and Immunology, 1969
- Variability of the potency of pertussis vaccinein relation to the number of bacteriaThe Journal of Pediatrics, 1954